Your browser doesn't support javascript.
loading
Secukinumab for the treatment of SAM syndrome associated with desmoglein-1 deficiency.
Frommherz, L H; Schempp, C M; Has, C.
Affiliation
  • Frommherz LH; Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Schempp CM; Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Has C; Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Br J Dermatol ; 184(4): 770-772, 2021 04.
Article in En | MEDLINE | ID: mdl-33205394
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Exfoliative / Antibodies, Monoclonal, Humanized Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Br J Dermatol Year: 2021 Document type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Exfoliative / Antibodies, Monoclonal, Humanized Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Br J Dermatol Year: 2021 Document type: Article Affiliation country: Germany